13F Holdings
中文EN

SR One Capital Management, LP

Redwood City CA · SEC CIK 0001910264

2026Q22026Q1 9 earlier quarters 🔒
$1.04B2026Q2 reported value
15Positions
95.1%Top 10 weight · largest 28.4%
0 / 2New / sold out
Reported value over time$1.04B2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

MANE 28.4%
ZBIO 12.3%
CRSP 10.7%
AVLN 10.5%
DSGN 9.1%
ODTX 6.8%
ALMS 5.3%
ORIC 4.8%
MLYS 4.1%
SPRY 3.1%

2026Q2 top buys estimated at quarter-end value

ORIC Added+$1.09M

2026Q2 top sells estimated at quarter-end value

Arcellx, Inc. Sold out-$269.44M
ORKA Sold out-$21.11M

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
MANE Veradermics, Inc. $295.29M28.42%2,401,868 00.0% — Unchanged
ZBIO Zenas BioPharma, Inc $127.86M12.31%5,037,854 00.0% — Unchanged
CRSP CRISPR Therapeutics AG $111.19M10.70%2,038,763 00.0% — Unchanged
AVLN Avalyn Pharma, Inc $108.92M10.48%3,308,649 3,308,649— — First reported
DSGN Design Therapeutics, Inc. $94.44M9.09%6,526,476 00.0% — Unchanged
ODTX Odyssey Therapeutics, Inc. $71.00M6.83%3,794,883 3,794,883— — First reported
ALMS Alumis Inc. $55.15M5.31%1,959,896 00.0% — Unchanged
ORIC ORIC Pharmaceuticals, Inc. $49.98M4.81%4,615,384 100,4552.2% $1.09M Added
MLYS Mineralys Therapeutics Inc. $42.20M4.06%1,563,966 00.0% — Unchanged
SPRY ARS Pharmaceuticals, Inc. $32.14M3.09%4,012,903 00.0% — Unchanged
— Mobia Medical, Inc $26.61M2.56%1,986,072 1,986,072— — First reported
NKTX Nkarta, Inc. $9.43M0.91%3,333,333 00.0% — Unchanged
OCS Oculis Holding AG $8.89M0.86%641,022 00.0% — Unchanged
RARE Ultragenyx Pharmaceutical Inc. $4.60M0.44%137,753 00.0% — Unchanged
— enGene Holdings Inc. $1.29M0.12%747,750 00.0% — Reappeared
— Arcellx, Inc. $00.00%0 -2,346,630-100.0% -$269.44M Sold out
ORKA Oruka Therapeutics, Inc $00.00%0 -430,330-100.0% -$21.11M Sold out